Download Full Text (1.3 MB)


  • Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
  • Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to weaken the bones. Researchers at The University of Texas MD Anderson Cancer Center are investigating treatments to -prevent cancer-related bone loss and fractures as well as fracture-related sequelae such as immobility and blood clots.
  • INBRIEF: Experimental Drug LOXO-101 Shrinks Tumors with NTRK Fusions/ Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer Triples Progression-Free Survival/ Immunotherapy Drug Nivolumab Reduces Tumor Burden in Patients with Metastatic Bladder Cancer
  • HOUSE CALL: Common Terms Used In Cancer Surgery- Cancer surgery is done in many ways for many reasons.
  • USEFULRESOURCES: Cancer Treatment Algorithms.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Ariza-Heredia, Ella; Alonso, Maria; Gulbis, Alison; Champlin, Richard; Stolar, Karen; Lu, Huifang; Hu, Mimi; Hong, David S.; Gomez, Daniel; Sharma, Padmanee; Hematopoietic Stem Cell Transplantation; Vaccines; Bone Resorption; Antineoplastic Agents; Clinical Trials as Topic; Neoplasms; Neoplasms -- therapy; larotrectinib; Sarcoma; Carcinoma, Non-Small-Cell Lung -- secondary; Radiotherapy; Urinary Bladder Neoplasms -- secondary; Immunotherapy; Nivolumab; Surgical Procedures, Operative.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 61, Number 07, July 2016